Zenas BioPharma, Inc.

ZBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$31.13-0.99%

2026-08-03

Financials

Valuation Metrics

Zenas BioPharma, Inc.'s Market Cap is $1.97B. At end of 2025 it was $1.69B. Ranked #2066 of 3,112 in US market (top 66%), #794 of 1,445 on NASDAQ (top 55%), #137 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 51%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.97B	US#2,066/3,112 Sec#137/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-425M	US—/3,112 Sec—/269
Total Assets	$748M	US#2,567/3,112 Sec#115/269
Net Assets	$336M	US#2,498/3,112 Sec#150/269
Value
P/B	5.85x	US#2,290/3,112 Sec#151/269
P/S	196.53x	US#2,925/3,112 Sec#189/269
FCF Yield	-10.71%	US—/3,112 Sec—/269
Profitability
ROE	-126.60%	US#2,878/3,112 Sec#227/269
ROA	-56.86%	US#2,988/3,112 Sec#231/269
Revenue Growth	-100.00%	US#2,948/3,112 Sec#190/269
Financial Health
Debt Ratio	122.64%	US#1,275/3,112 Sec#175/269
Total Debt	$352M	US#1,979/3,112 Sec#67/269
FCF	$-210M	US#2,741/3,112 Sec#221/269
Cash	$500M	US#1,069/3,112 Sec#56/269
Current Ratio	11.94x	US#209/3,112 Sec#69/269
Performance
1Y Return	102.01%	US#390/3,112 Sec#90/269
1M Return	14.32%	US#313/3,112 Sec#13/269
From 52W High	-30.20%	US#2,187/3,112 Sec#166/269
1Y MDD	-64.79%	US#2,827/3,112 Sec#232/269
Trading
Volume	419,724 shares	US#2,187/3,112 Sec#215/269
Trading Value	$13M	US#2,200/3,112 Sec#173/269
Per Share
EPS	$-8.12	US—/3,112 Sec—/269
BPS	$5.21	US#2,210/3,112 Sec#130/269